Advanced search
Publication Cover
Pragmatic and Observational Research Volume 12, 2021 - Issue
Submit an article Journal homepage
120
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV1 Decline in a COPD Population

Hannah R Whittaker1 National Heart and Lung Institute, Imperial College London, London, UKCorrespondence[email protected]
View further author information
,
Steven J Kiddle2 MRC Biostatistics Unit, University of Cambridge, Cambridge, UKORCID Iconhttps://orcid.org/0000-0003-4350-7437View further author information
ORCID Icon &
Jennifer K Quint1 National Heart and Lung Institute, Imperial College London, London, UKORCID Iconhttps://orcid.org/0000-0003-0149-4869View further author information
ORCID Icon
Pages 119-130 | Published online: 01 Sep 2021

References

  • Whittaker H, Quint JK. Using routine health data for research: the devil is in the detail. Thorax. 2020;75:714–715. doi:10.1136/thoraxjnl-2020-214821
  • Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99. doi:10.2147/COPD.S27480
  • Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245. doi:10.1183/09031936.00133805
  • Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–1192. doi:10.1056/NEJMoa1105482
  • Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098
  • Rothnie KJ, Chandan JS, Goss HG, Mullerova H, Quint JK. Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care. Int J Chron Obstruct Pulmon Dis. 2017;12:1663–1668. doi:10.2147/COPD.S133891
  • Quint JK, Mullerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the clinical practice research datalink (CPRD-GOLD). BMJ Open. 2014;4(7):e005540. doi:10.1136/bmjopen-2014-005540
  • Whittaker HR, Pimenta JM, Jarvis DA-O, Kiddle SA-O, Quint JA-O. Characteristics associated with accelerated lung function decline in a primary care population with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:3079. (1178-2005 (Electronic)). doi:10.2147/COPD.S278981
  • Whittaker HR, Mullerova H, Jarvis D, et al. Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting. Int J Chron Obstruct Pulmon Dis. 2019;14:1063–1073. doi:10.2147/COPD.S200919
  • Whittaker HR, Bloom C, Morgan A, Jarvis D, Kiddle SJ, Quint JK. Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients. Eur Respir J. 2020;2000918. doi:10.1183/13993003.00918-2020
  • Watz H, Tetzlaff K, Magnussen H, et al. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res. 2018;19(1):251. doi:10.1186/s12931-018-0944-3
  • Whittaker HR, Jarvis D, Sheikh MR, Kiddle SJ, Quint JK. Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2019;20(1):277. doi:10.1186/s12931-019-1249-x
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5. doi:10.1183/09041950.005s1693
  • Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax. 2006;61(6):472–477. doi:10.1136/thx.2005.052449
  • Tashkin DP, Li N, Kleerup EC, et al. Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD. Respir Res. 2014;15(1):102. doi:10.1186/s12931-014-0102-5
  • Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742. doi:10.1183/09031936.00129607
  • Kim J, Yoon HI, Oh Y-M, et al. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1819–1827. doi:10.2147/COPD.S87766
  • Luoto J, Pihlsgard M, Wollmer P, Elmstahl S. Relative and absolute lung function change in a general population aged 60–102 years. Eur Respir J. 2019;53(3):3. doi:10.1183/13993003.01812-2017
  • Magnussen H, Disse B, Rodriguez-Roisin R, et al. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med. 2014;371(14):1285–1294. doi:10.1056/NEJMoa1407154
  • Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.847
  • Calverley PM, Anderson JA, Brook RD, et al. Fluticasone furoate, vilanterol and lung function decline in patients with moderate COPD and heightened cardiovascular risk. Am J Respir Crit Care Med. 2017.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.